Author

Nancy Silliman

Observed names: N. P. Silliman, N. Silliman, NANCY PAUL SILLIMAN, Nancy P. Silliman, Nancy Paul Silliman, Silliman, N, Silliman, Nancy

Institutions: Boston University, Brigham and Women's Hospital, The Royal Free Hospital, University College London, University of Pennsylvania, Stanford University

Observed institutions: Boston University, Brigham and Women's Hospital, United States Food and Drug Administration, Center for Drug Evaluation and Research, Alnylam Pharmaceuticals (United States), The Royal Free Hospital, Alexion Pharmaceuticals (United States), University College London, Alexion Pharma (Switzerland), University of Pennsylvania, Stanford University

OpenAlex ID: A5069274229

Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy

2024 · Marianna Fontana, John L. Berk, et al. · New England Journal of Medicine · 472

Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo‐controlled phase I/II trial of CAT‐192

2006 · Christopher P. Denton, Peter A. Merkel, et al. · Arthritis & Rheumatism · 448

Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial

2008 · Peter A. Merkel, Nancy P. Silliman, et al. · Arthritis Care & Research · 134

Patterns and predictors of change in outcome measures in clinical trials in scleroderma: An individual patient meta‐analysis of 629 subjects with diffuse cutaneous systemic sclerosis

2012 · P. A. Merkel, N. P. Silliman, et al. · Arthritis & Rheumatism · 76

Hierarchical Selection Models With Applications in Meta-Analysis

1997 · Nancy Paul Silliman · Journal of the American Statistical Association · 47

Nonparametric classes of weight functions to model publication bias

1997 · N. Silliman · Biometrika · 20

Progression of liver disease in children and adults with lysosomal acid lipase deficiency

2017 · Barbara K. Burton, Nancy Silliman, et al. · Current Medical Research and Opinion · 19

Study Design and Rationale of Helios-b: a Phase 3 Study to Evaluate the Clinical Efficacy and Safety of Vutrisiran in Patients With Attr Amyloidosis With Cardiomyopathy

2020 · Rebecca Shilling, Verena Karsten, et al. · Journal of the American College of Cardiology · 13

Applications of a Mixture Survival Model With Covariates to the Analysis of a Depression Prevention Trial

1996 · JOEL B. GREENHOUSE, NANCY PAUL SILLIMAN · Statistics in Medicine · 12

Helicobacter pylori and Early Duodenal Ulcer Status Post‐Treatment: a Review

2001 · Joette M. Meyer, Nancy P. Silliman, et al. · Helicobacter · 7

Validation and Evaluation of Memorial Symptom Assessment Scale Short-Form (Msas-Sf)In a Romanian Cohort of Hemodialysis Patients

2015 · Tatsuyoshi Ikenoue, M. Wang, et al. · The Medical-Surgical Journal

Dialysis. Epidemiology, Outcome Research, Health Services 1

2014 · T. Ikenoue, K. Koike, et al. · Nephrology Dialysis Transplantation

Helicobacter pylori eradication improves duodenal ulcer prevalence at 4–6 weeks post-treatment using omeprazole-based regimens

2000 · Joette M. Meyer, Nancy P. Silliman, et al. · Gastroenterology

Works count: 15

Citation count: 1,257

H-index: 10

I10-index: 10